Profound Medical Corp. (TSX:PRN)
Canada
· Delayed Price · Currency is CAD 8.21
-0.47 (-5.41%)
Mar 31, 2025, 3:35 PM EST
Profound Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -27.82 | -28.32 | -28.67 | -30.7 | -21.62 | Upgrade
|
| Depreciation & Amortization | 0.94 | 0.93 | 1 | 1.01 | 0.81 | Upgrade
|
| Other Amortization | - | - | 0.6 | 0.87 | 0.73 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 2.52 | - | - | Upgrade
|
| Stock-Based Compensation | 2.58 | 3.42 | 4.24 | 7.21 | 3.02 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.31 | 0.15 | - | - | - | Upgrade
|
| Other Operating Activities | -0.39 | 0.87 | 0.13 | 0.13 | 1.13 | Upgrade
|
| Change in Accounts Receivable | 0.19 | -0.96 | -1.42 | 2 | -4.03 | Upgrade
|
| Change in Inventory | 0.66 | 0.35 | -1.86 | -2.49 | -2.14 | Upgrade
|
| Change in Accounts Payable | 0.82 | 1.35 | -0.57 | -0.36 | 0.1 | Upgrade
|
| Change in Income Taxes | - | -0.3 | 0.31 | -0.01 | 0 | Upgrade
|
| Change in Other Net Operating Assets | 0.03 | -0.16 | -2.09 | -0.01 | 1.25 | Upgrade
|
| Operating Cash Flow | -23.45 | -22.61 | -25.8 | -22.36 | -20.57 | Upgrade
|
| Capital Expenditures | - | - | - | -0.03 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.56 | -0.35 | Upgrade
|
| Investing Cash Flow | - | - | - | -0.59 | -0.35 | Upgrade
|
| Long-Term Debt Issued | - | - | 7.27 | - | - | Upgrade
|
| Total Debt Issued | - | - | 7.27 | - | - | Upgrade
|
| Long-Term Debt Repaid | -2.56 | -0.91 | -0.36 | -0.39 | -9.61 | Upgrade
|
| Total Debt Repaid | -2.56 | -0.91 | -0.36 | -0.39 | -9.61 | Upgrade
|
| Net Debt Issued (Repaid) | -2.56 | -0.91 | 6.92 | -0.39 | -9.61 | Upgrade
|
| Issuance of Common Stock | 62.15 | 2.67 | 0.26 | 6.43 | 103.68 | Upgrade
|
| Other Financing Activities | -4.9 | - | -0.15 | -0.1 | -6.64 | Upgrade
|
| Financing Cash Flow | 54.7 | 1.76 | 7.03 | 5.95 | 87.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.54 | 0.55 | -1.87 | 0.24 | 2.6 | Upgrade
|
| Net Cash Flow | 28.7 | -20.3 | -20.64 | -16.76 | 69.11 | Upgrade
|
| Free Cash Flow | -23.45 | -22.61 | -25.8 | -22.39 | -20.57 | Upgrade
|
| Free Cash Flow Margin | -219.60% | -314.06% | -386.17% | -325.80% | -281.68% | Upgrade
|
| Free Cash Flow Per Share | -0.95 | -1.07 | -1.24 | -1.09 | -1.19 | Upgrade
|
| Levered Free Cash Flow | -15.05 | -13.15 | -18.78 | -7.22 | -13.31 | Upgrade
|
| Unlevered Free Cash Flow | -15.05 | -13.15 | -18.68 | -7.18 | -12.97 | Upgrade
|
| Change in Net Working Capital | -2.1 | -0.41 | 6.02 | -3.26 | 5.39 | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.